Pontifax Management 4 G.P. (2015) Ltd. - 10%+ Owner at Eloxx Pharmaceuticals, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Pontifax Management 4 G.P. (2015) Ltd. since 21 Oct 2025

Reported holdings for Pontifax Management 4 G.P. (2015) Ltd. in Eloxx Pharmaceuticals, Inc.

Form 4 holding 10%+ Owner

Eloxx Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
616,592
Estimated value
$443,946
Report date
13 May 2021
Price
$0.7200
Ownership
By Pontifax Investment Fund

Transaction history for Pontifax Management 4 G.P. (2015) Ltd. in Eloxx Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .